SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Leap Therapeutics Q1 EPS $(0.550) Down From $(0.470) YoY, Sales $375.000K

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.550) per share. This is a 17.02 percent decrease over losses of $(0.470) per share from the same period last year. The company reported $375.000 thousand

Benzinga · 05/14/2020 11:10

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.550) per share. This is a 17.02 percent decrease over losses of $(0.470) per share from the same period last year. The company reported $375.000 thousand in sales this quarter.